RAVEL BIOTECHNOLOGY
Ravel Biotechnology markets an analytic technology platform capable of early detection of disease from cell-free DNA. The technology platform enables the accelerated development and validation of screening tests for a wide range of diseases from a single analyte, cell-free DNA. Thus providing the opportunity to screen for a multitude of diseases from a single blood draw. The company was co-founded by Erik Gafni and Nathan Boley in 2018 and is based in San Francisco, California.
RAVEL BIOTECHNOLOGY
Industry:
Analytics Biotechnology Genetics Health Care
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.ravel.bio
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Apache Global Site Tag
Similar Organizations
Current Employees Featured
Founder
Investors List
Hemi Ventures
Hemi Ventures investment in Venture Round - Ravel Biotechnology
rocketship.vc
rocketship.vc investment in Seed Round - Ravel Biotechnology
